Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
impel neuropharma
life sciences
medical device
migraine
2
×
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
acute migrane
alder biopharmaceutical
allergan
american academy of neurology
amgen
atogepant
bain capital
bausch health
biohaven
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
breast cancer
brian abrahams
calcitonin gene-related peptide
desmoid tumor
detroit blog main
detroit top stories
dihydroergotamine
dihydroergotamine mesylate
drugs
eli lilly
eptinezumab
erenumab
What
companies
2
×
drug
migraine
2
×
activity
approval
arguments
big
biotech
class
commercialized
competitors
days
decades
dog
drugs
fda
firm
hasn’t
ipo
ipos
leading
line
make
meeting
neuro
new
oral
pfizer
place
potential
prep
satsuma
securing
slowed
spinout
springworks
stopped
summer
therapies
won
Language
unset
Current search:
migraine
×
companies
×
migraine
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments